BR0108376A - Composto, polepeptìdeo, ácido nucleico, vetor, vìrus recombinante defectivo, anticorpo ou fragmento ou derivado de anticorpo, composição farmacêutica, processos para a seleção ou a caracterização de moléculas ativas e para a produção de um composto peptìdico, proteìna, célula, e, mamìfero não-humano - Google Patents
Composto, polepeptìdeo, ácido nucleico, vetor, vìrus recombinante defectivo, anticorpo ou fragmento ou derivado de anticorpo, composição farmacêutica, processos para a seleção ou a caracterização de moléculas ativas e para a produção de um composto peptìdico, proteìna, célula, e, mamìfero não-humanoInfo
- Publication number
- BR0108376A BR0108376A BR0108376-7A BR0108376A BR0108376A BR 0108376 A BR0108376 A BR 0108376A BR 0108376 A BR0108376 A BR 0108376A BR 0108376 A BR0108376 A BR 0108376A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- antibody
- protein
- mammal
- characterization
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 title 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 230000002950 deficient Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 101710176122 28 kDa heat- and acid-stable phosphoprotein Proteins 0.000 abstract 1
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 abstract 1
- 102100027336 Regenerating islet-derived protein 3-alpha Human genes 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 102000045222 parkin Human genes 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
"COMPOSTO, POLIPEPTìDEO, áCIDO NUCLEICO, VETOR, VìRUS RECOMBINANTE DEFECTIVO, ANTICORPO OU FRAGMENTO OU DERIVADO DE ANTICORPO, COMPOSIçãO FARMACêUTICA, PROCESSOS PARA A SELEçãO OU A CARACTERIZAçãO DE MOLéCULAS ATIVAS E PARA A PRODUçãO DE UM COMPOSTO PEPTìDICO, PROTEINA, CéLULA, E, MAMìFERO NãO-HUMANO". A presente invenção refere-se a compostos inéditos e a suas utilizações, principalmente farmacêuticas, diagnósticas ou como alvos farmacológicos. Mais particularmente, a presente invenção refere-se a uma proteína inédita, denominada PAP1, e também a peptídeos e compostos inéditos capazes de modular pelo menos parcialmente a atividade da parkina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001980A FR2805266B1 (fr) | 2000-02-17 | 2000-02-17 | Compositions utilisables pour reguler l'activite de la parkine |
| US19848900P | 2000-04-18 | 2000-04-18 | |
| PCT/FR2001/000461 WO2001060857A2 (fr) | 2000-02-17 | 2001-02-15 | Compositions utilisables pour reguler l'activite de la parkine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0108376A true BR0108376A (pt) | 2003-03-11 |
Family
ID=26212182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0108376-7A BR0108376A (pt) | 2000-02-17 | 2001-02-15 | Composto, polepeptìdeo, ácido nucleico, vetor, vìrus recombinante defectivo, anticorpo ou fragmento ou derivado de anticorpo, composição farmacêutica, processos para a seleção ou a caracterização de moléculas ativas e para a produção de um composto peptìdico, proteìna, célula, e, mamìfero não-humano |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7132396B2 (pt) |
| EP (1) | EP1259606B1 (pt) |
| KR (1) | KR100811926B1 (pt) |
| AT (1) | ATE466083T1 (pt) |
| AU (1) | AU2001235696A1 (pt) |
| BR (1) | BR0108376A (pt) |
| CA (1) | CA2400256C (pt) |
| CY (1) | CY1111004T1 (pt) |
| DE (1) | DE60141948D1 (pt) |
| IL (3) | IL151211A0 (pt) |
| MX (1) | MXPA02007869A (pt) |
| NO (1) | NO20023914L (pt) |
| NZ (1) | NZ520802A (pt) |
| WO (1) | WO2001060857A2 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1480994A1 (en) * | 2001-12-14 | 2004-12-01 | Incyte Genomics, Inc. | Neurotransmission-associated proteins |
| WO2004074446A2 (en) * | 2003-02-18 | 2004-09-02 | Cedars-Sinai Medical Center | Parkin interacting polypeptides and methods of use |
| PL2195645T3 (pl) * | 2007-09-11 | 2014-12-31 | Cancer Prevention & Cure Ltd | Metoda wspomagająca diagnostykę i terapię astmy i rak płuc |
| CN109297780B (zh) * | 2018-10-23 | 2021-01-01 | 东华理工大学 | 一种液塑限联合测定法中的取样方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004500813A (ja) * | 1999-12-21 | 2004-01-15 | インサイト・ゲノミックス・インコーポレイテッド | 小胞輸送タンパク質 |
| WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US20030220240A1 (en) * | 2000-12-21 | 2003-11-27 | Tang Y. Tom | Vesicle trafficking proteins |
-
2001
- 2001-02-15 AU AU2001235696A patent/AU2001235696A1/en not_active Abandoned
- 2001-02-15 AT AT01907820T patent/ATE466083T1/de active
- 2001-02-15 CA CA2400256A patent/CA2400256C/fr not_active Expired - Fee Related
- 2001-02-15 BR BR0108376-7A patent/BR0108376A/pt active Search and Examination
- 2001-02-15 IL IL15121101A patent/IL151211A0/xx unknown
- 2001-02-15 KR KR1020027010630A patent/KR100811926B1/ko not_active IP Right Cessation
- 2001-02-15 WO PCT/FR2001/000461 patent/WO2001060857A2/fr active Application Filing
- 2001-02-15 EP EP01907820A patent/EP1259606B1/fr not_active Expired - Lifetime
- 2001-02-15 MX MXPA02007869A patent/MXPA02007869A/es active IP Right Grant
- 2001-02-15 NZ NZ520802A patent/NZ520802A/en not_active IP Right Cessation
- 2001-02-15 DE DE60141948T patent/DE60141948D1/de not_active Expired - Lifetime
- 2001-02-20 US US09/785,548 patent/US7132396B2/en not_active Expired - Fee Related
-
2002
- 2002-08-12 IL IL151211A patent/IL151211A/en not_active IP Right Cessation
- 2002-08-16 NO NO20023914A patent/NO20023914L/no not_active Application Discontinuation
-
2006
- 2006-03-28 US US11/390,195 patent/US8273548B2/en not_active Expired - Fee Related
-
2008
- 2008-08-07 IL IL193310A patent/IL193310A/en not_active IP Right Cessation
-
2010
- 2010-07-27 CY CY20101100700T patent/CY1111004T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20023914L (no) | 2002-10-11 |
| CA2400256A1 (fr) | 2001-08-23 |
| CY1111004T1 (el) | 2015-06-11 |
| IL151211A0 (en) | 2003-04-10 |
| DE60141948D1 (de) | 2010-06-10 |
| WO2001060857A2 (fr) | 2001-08-23 |
| EP1259606B1 (fr) | 2010-04-28 |
| NZ520802A (en) | 2005-02-25 |
| US8273548B2 (en) | 2012-09-25 |
| MXPA02007869A (es) | 2003-02-10 |
| IL151211A (en) | 2010-05-31 |
| CA2400256C (fr) | 2014-09-09 |
| IL193310A0 (en) | 2011-08-01 |
| EP1259606A2 (fr) | 2002-11-27 |
| AU2001235696A1 (en) | 2001-08-27 |
| ATE466083T1 (de) | 2010-05-15 |
| IL193310A (en) | 2011-12-29 |
| US20060287230A1 (en) | 2006-12-21 |
| NO20023914D0 (no) | 2002-08-16 |
| KR100811926B1 (ko) | 2008-03-10 |
| US7132396B2 (en) | 2006-11-07 |
| KR20020089352A (ko) | 2002-11-29 |
| US20020155577A1 (en) | 2002-10-24 |
| WO2001060857A3 (fr) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Complete disulfide bond assignment of a recombinant immunoglobulin G4 monoclonal antibody | |
| Camporeale et al. | K8 and K12 are biotinylated in human histone H4 | |
| Heinz et al. | The action of neutrophil serine proteases on elastin and its precursor | |
| JP5002603B2 (ja) | 新規なペプチド及びこれの用途 | |
| ATE476654T1 (de) | Plattform für protein-profiling | |
| Taddese et al. | In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24 | |
| Belew et al. | Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin | |
| Munawar et al. | Isolation and characterization of Bradykinin potentiating peptides from Agkistrodon bilineatus venom | |
| DE60114018D1 (de) | Von zellen präsentierte peptide | |
| Zhang | Smits | |
| PT1079849E (pt) | Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica | |
| Samgina et al. | EThcD discrimination of isomeric leucine/isoleucine residues in sequencing of the intact skin frog peptides with intramolecular disulfide bond | |
| EP1766011A1 (en) | Polypeptide ligands containing linkers | |
| Fukai et al. | Rat plasma fibronectin contains two distinct chemotactic domains for fibroblastic cells | |
| BR0108376A (pt) | Composto, polepeptìdeo, ácido nucleico, vetor, vìrus recombinante defectivo, anticorpo ou fragmento ou derivado de anticorpo, composição farmacêutica, processos para a seleção ou a caracterização de moléculas ativas e para a produção de um composto peptìdico, proteìna, célula, e, mamìfero não-humano | |
| Haniu et al. | Human Dickkopf‐1 (huDKK1) protein: Characterization of glycosylation and determination of disulfide linkages in the two cysteine‐rich domains | |
| Pasch et al. | PEGylated sequence-controlled macromolecules using supramolecular binding to target the Taspase1/Importin α interaction | |
| ATE294816T1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| Toyama et al. | Structure–function relationship of new crotamine isoform from the Crotalus durissus cascavella | |
| Baglia et al. | The Apple 1 and Apple 4 domains of factor XI act synergistically to promote the surface-mediated activation of factor XI by factor XIIa | |
| US20100212030A1 (en) | Use of n-terminal and c-terminal proteomics technology to enhance protein therapeutics and diagnostics | |
| Caetano et al. | Expression and purification of recombinant vascular endothelial-statin | |
| Bauer et al. | Isolation and identification of intact chromogranin A and two N-terminal processing products, vasostatin I and II, from bovine adrenal medulla chromaffin granules by chromatographic and mass spectrometric methods | |
| Chino et al. | Chemical synthesis of human β-defensin (hBD)-1,-2,-3 and-4: optimization of the oxidative folding reaction | |
| WO2005030798A3 (en) | TNFαCONVERTING ENZYME INHIBITORY AGENTS AND STIMULATORY AGENTS- |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |